Archives of Clinical Infectious Diseases

Published by: Kowsar

Diagnostic Performance of Brain Natriuretic Peptide in Patients Suspected to Sepsis

Mitra Barati 1 , * , Leila Farnia 2 , Mohammad Ali Eshaghi 3 , Mahshid Talebi-Taher 4 and Newsha Farhadi 5
Authors Information
1 Research Center of Pediatric Infectious Diseases, Iran University of Medical Sciences, Tehran, IR Iran
2 Department of Internal Diseases, Iran University of Medical Sciences, Tehran, IR Iran
3 Department of Infectious Diseases, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Infectious Diseases, Antimicrobial Resistance Research Center, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, IR Iran
5 Department of Internal Medicine, Faculty of Medicine, Shahed University, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: October 25, 2013, 8 (4); e19310
  • Published Online: October 15, 2013
  • Article Type: Research Article
  • Received: July 12, 2013
  • Revised: August 9, 2013
  • Accepted: September 22, 2013
  • DOI: 10.5812/archcid.19310

To Cite: Barati M, Farnia L, Eshaghi M A, Talebi-Taher M, Farhadi N. Diagnostic Performance of Brain Natriuretic Peptide in Patients Suspected to Sepsis, Arch Clin Infect Dis. 2013 ; 8(4):e19310. doi: 10.5812/archcid.19310.

Copyright © 2013, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Sibbald WJ, Vincent JL. Roundtable Conference on Clinical Trials for the Treatment of Sepsis. Brussels, March 12-14, 1994. Chest. 1995; 107(2): 522-7[PubMed]
  • 2. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE. Endotoxemia in human septic shock. Chest. 1991; 99(1): 169-75[PubMed]
  • 3. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999; 340(3): 207-14[DOI][PubMed]
  • 4. Vesely DL. 1992;
  • 5. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990; 113(3): 227-42[PubMed]
  • 6. Price S, Anning PB, Mitchell JA, Evans TW. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J. 1999; 20(10): 715-24[PubMed]
  • 7. Hoffmann U, Brueckmann M, Bertsch T, Liebetrau C, Borggrefe M, Huhle G, et al. 1049-105 Increased levels of Nt-ProANP and Nt-ProBrain natriuretic peptide as markers of cardiac depression in septic patiens. J Am College Cardiol. 2004; 43(5, Supplement 1)[DOI]
  • 8. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med. 2004; 32(3): 660-5[PubMed]
  • 9. Zhang XH, Dong Y, Chen YD, Zhou P, Wang JD, Wen FQ. Serum N-terminal pro-brain natriuretic peptide level is a significant prognostic factor in patients with severe sepsis among Southwest Chinese population. Eur Rev Med Pharmacol Sci. 2013; 17(4): 517-21[PubMed]
  • 10. Wang F, Wu Y, Tang L, Zhu W, Chen F, Xu T, et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis. Crit Care. 2012; 16(3)[DOI][PubMed]
  • 11. Zhao HY, Liu F, Lu J, Liu D, An YZ. [The prognostic value of N-terminal pro-B-type natriuretic peptide in patients with severe sepsis and septic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011; 23(8): 467-70[PubMed]
  • 12. Chen Y, Li C. Prognostic significance of brain natriuretic peptide obtained in the ED in patients with SIRS or sepsis. Am J Emerg Med. 2009; 27(6): 701-6[DOI][PubMed]
  • 13. Zhao HY, An YZ, Liu F. [Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009; 21(5): 293-5[PubMed]
  • 14. Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettila V, Finnsepsis Study Group . Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med. 2007; 35(5): 1277-83[DOI][PubMed]
  • 15. Maeder M, Ammann P, Kiowski W, Rickli H. B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction. Eur J Heart Fail. 2005; 7(7): 1164-7[DOI][PubMed]
  • 16. Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care. 2002; 6(6): 500-8[PubMed]
  • 17. Tomaru Ki K, Arai M, Yokoyama T, Aihara Y, Sekiguchi Ki K, Tanaka T, et al. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 2002; 34(6): 649-59[DOI][PubMed]
  • 18. He Q, LaPointe MC. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension. 1999; 33(1 Pt 2): 283-9[PubMed]
  • 19. Kuwahara K, Saito Y, Harada M, Ishikawa M, Ogawa E, Miyamoto Y, et al. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation. 1999; 100(10): 1116-24[PubMed]
  • 20. Phua J, Lim TK, Lee KH. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med. 2005; 33(9): 2094-13[PubMed]
  • 21. Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest. 2006; 129(5): 1349-66[DOI][PubMed]
  • 22. Kandil E, Burack J, Sawas A, Bibawy H, Schwartzman A, Zenilman ME, et al. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg. 2008; 143(3): 242-6[DOI][PubMed]
  • 23. Rivers EP, McCord J, Otero R, Jacobsen G, Loomba M. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med. 2007; 22(6): 363-73[PubMed]
  • 24. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010; 14(1)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments